SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000920465-17-000077
Filing Date
2017-12-13
Accepted
2017-12-13 21:05:36
Documents
1
Period of Report
2017-12-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_151321712188537.html 4  
1 FORM 4 wf-form4_151321712188537.xml 4 3943
  Complete submission text file 0000920465-17-000077.txt   5366
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O LA JOLLA PHARMACEUTICAL COMPANY LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address
Douglass Laura L. (Reporting) CIK: 0001589362 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36282 | Film No.: 171255044